DALLAS, April 16 After only four weeks, people who took an investigational drug were able to increase their good cholesterol levels by 34 percent, according to a report in todays rapid access Circulation: Journal of the American Heart Association.
Also, 198 people lowered their LDL cholesterol (the bad cholesterol) by 7 percent.
The drug, called a CETP inhibitor, works by blocking the action of the cholesteryl ester transfer protein, which is known to lower HDL (the good cholesterol).
CETP represents an important target because this protein plays a key role in HDL metabolism. In fact, a genetic deficiency of CETP is the main reason for high HDL in Asian populations, says study author John Kastelein, M.D., Ph.D., from the Academic Medical Center in Amsterdam, The Netherlands.
The study was designed as a 12-week, multi-center, randomized trial evaluating the efficacy and safety of three different doses of the drug. A clear dose-dependent decrease in CETP activity was observed after one week, reaching a maximum decrease of 37 percent from baseline in the high-dose group after four weeks. After four weeks, participants taking the highest dose, 900 mg, had a 33.9 percent increase in HDL levels.
Except for some mild gastrointestinal side-effects, there were no major adverse effects from the new drug.
Although these results hold promise, further studies are needed to investigate whether the increase in HDL cholesterol translates into a reduction in coronary artery disease risk, says Kastelein.
Page: 1 Related medicine news :1
Contact: Carole Bullock
American Heart Association
. Hormone therapy controversy raises drug safety issues2
. NYU Child Study Center raises a record $3.4 million at Seventh Annual Child Advocacy Award Dinner3
. Heavy drinking raises the risk of early death after heart attack4
. Lord Sainsbury praises the work of the UKs Innovative Manufacturing Research Centres5
. New study raises questions about the number of people in the UK who could be incubating vCJD6
. Study raises concerns about tablet splitting7
. Parents heart attack or stroke raises risk in their middle-aged children8
. NYU Child Study Center raises nearly $3.2 million at annual child advocacy award dinner9
. Study raises prospect of practical vaccine for metastatic melanoma10
. AAS praises Presidents Commission for emphasizing suicide prevention11
. New buzz on coffee: Its not the caffeine that raises blood pressure